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The podocyte has a central role in the glomerular filtration
barrier typified by a sophisticated morphology of highly
organized primary (major) and secondary (foot) processes.
The molecular makeup of foot processes is well
characterized, but that of major processes is poorly known.
Previously, we profiled the glomerular transcriptome
through large-scale sequencing and microarray profiling.
Unexpectedly, the survey found expression of three neuronal
proteins (Huntingtin interacting protein 1 (Hip1), neurofascin
(Nfasc), and olfactomedin-like 2a (Olfml2a)), all enriched in
the glomerulus. These proteins were expressed exclusively by
podocytes, wherein they localized to major processes as
verified by RT–PCR, western blotting, immunofluorescence,
and immunoelectron microscopy. During podocyte
development, these proteins colocalized with vimentin,
confirming their association with major processes. Using
immunohistochemistry, we found coexpression of Hip1
and Olfml2a along with the recognized podocyte markers
synaptopodin and Pdlim2 in glomerular crescents of human
kidneys, indicating the presence of podocytes in these
lesions. Thus, three neuronal proteins are highly expressed in
podocyte major process. Using these new markers we found
that podocytes contribute to the formation of glomerular
crescents.
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The glomerulus comprises a tangled network of capillaries
surrounded by a urinary space and Bowman’s capsule.
The filtration of primary urine occurs through the capillary
wall of the glomerulus. This filtration barrier is essentially
composed of three layers: (1) the glomerular basement
membrane, which serves as a foundation and support;
(2) fenestrated endothelial cells, located on the inside; and
(3) visceral epithelial cells (podocytes), located on the outside
of the glomerular capillary.1
The podocyte is a highly specialized epithelial cell with a
remarkably sophisticated architecture.2 It has a prominent
cell body with large cytoplasmic projections named major
processes, which further extend into smaller processes known
as foot processes. The foot processes interdigitate as they
wrap around and envelope the capillaries. The adjacent foot
processes interact and are connected by a specialized cell–cell
junction termed the slit diaphragm.2–4 Mutations in slit
diaphragm proteins cause inherited forms of proteinuria,1
which underlines the importance of these structures in the
filtration barrier.
Podocytes are dynamic cells with a prominent cyto-
skeleton that can effectively respond to changes in their
extracellular environment.5 This cytoskeletal machinery is
vital for a sustained kidney filtration, as defects in
cytoskeleton-regulating proteins of podocyte foot processes
result in proteinuria.5 Bundles of microtubules and inter-
mediate filaments support major processes, whereas the
cytoskeleton of foot processes is composed mainly of actin
filaments.2,5,6 This feature confirms an obvious morphologi-
cal difference between these two structures, thus contributing
to their molecular and functional divergence. The molecular
composition of foot process is rather well characterized.4 This
includes basal, slit diaphragm, and apical plasma membrane
protein complexes connected by a number of linker proteins
and actin cytoskeleton.4,5 In contrast to this, the mole-
cular nature of major processes is still poorly understood.
Besides microtubules and the intermediate filament protein
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vimentin,2,6 the components that form these cellular projec-
tions are largely unknown.
We have previously identified several highly glomerulus-
enriched transcripts using large-scale sequencing and micro-
array profiling.7 In this study, we are characterizing further
three of these glomerular transcripts. All three proteins in the
kidney are expressed only by podocytes, wherein they localize
to major processes. The specific expression in podocyte major
processes suggests that they have a dedicated role in the
formation of these peculiar cellular projections. Furthermore,
we use these novel podocyte markers to demonstrate that
podocytes are present in glomerular crescents, an issue that
has been a matter of controversy.
RESULTS
Previously, we have profiled the glomerular transcriptome
through large-scale sequencing and microarray profiling.7
In this approach, we chose three transcripts, Huntingtin
interacting protein 1 (Hip1), neurofascin (Nfasc), and
olfactomedin-like 2a (Olfml2a), which were enriched in the
glomerulus, for a more detailed analysis. These genes were
chosen for further studies because their biology was poorly
understood, and their role and expression in the kidney were
completely uncharacterized.
Expression of Hip1 in mature and developing kidney
First, we analyzed the expression of Hip1 in the kidney
through reverse transcriptase–PCR (RT–PCR). The PCR
product for Hip1 was amplified in glomeruli, whereas no
expression was detected in the rest of the kidney lacking
glomeruli (Figure 1). The control experiment with glycer-
aldehyde 3–phosphate dehydrogenase showed strong signal in
both lanes, whereas podocin, a known glomerulus-specific
transcript, gave significantly stronger signal in the glomerular
fraction. Next, we generated a polyclonal antibody against the
human Hip1 protein. By using western blotting of human
kidney lysates, our anti-Hip1 antibody detected a band of
expected size (B115–kDa) in the glomerulus as opposed to
the rest of the kidney, which appeared completely negative
(Figure 1). A similar expression pattern was observed for
nephrin, a known podocyte-specific protein. The control
experiment with b-actin antibody showed clear signal in both
lysates.
In immunofluorescence, Hip1 antibody showed intense
staining in the glomeruli, and no signal was detected in the
extraglomerular areas (Figures 2a and 3a). Double staining
with foot process marker nephrin showed that Hip1 was
located at the side of the urinary space of nephrin (Figure 3b
and c). This indicated expression in podocytes. Occasionally,
some overlapping reactivity with nephrin was observed
(arrow, Figure 3c). Double labeling with vimentin showed
that Hip1 colocalized with this major process marker
(Figure 3d). Immunoelectron microscopy was used to
confirm the subcellular localization of Hip1. Gold label for
Hip1 was observed mostly in major processes (Figure 4a).
Quantitatively, we detected a total of 176 gold labels in
glomeruli, of which 96 (55%) were located in major
processes. In addition, few labels were occasionally detected
in foot processes (Figure 4a). No significant signal for Hip1
was found outside podocytes.
To confirm the association of Hip1 with major processes,
we investigated the expression of Hip1 during podocyte
development. The two earliest stages of development, vesicle
and S-shaped stages, showed no Hip1 expression (data not
shown). In the capillary stage glomerulus, a stage wherein
the formation of major processes begins, immunoreactivity
for Hip1 was first detected (Figure 5a and b). At this stage,
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Figure 1 | Expression of Huntingtin interacting protein 1
(Hip1), neurofascin (Nfasc), and olfactomedin-like 2a
(Olfml2a) in the kidney as analyzed with reverse
transcriptase–PCR (RT–PCR) and western blotting (WB). We
compared the expression in the glomerular fraction with the
rest of the kidney depleted of glomeruli. The transcripts are all
amplified in the glomeruli, whereas no (or very weak) expression
is detected in the rest of the kidney. The control reaction with
podocin, a known glomerulus-specific transcript, is detected in
the glomerular fraction, whereas glyceraldehyde 3–phosphate
dehydrogenase (GAPDH) is detected in both the glomerular
fractions and the rest of the kidney fractions. In WB, the
antibodies directed against Hip1, Nfasc, and Olfml2a show
immunoreactivity in the glomerular fraction, whereas no
(or very weak) band is visible in the rest of the kidney lysate.
The sizes of proteins detected are as follows: Hip1 B115 kDa,
Nfasc B185 kDa, and Olfml2a B110 kDa. The control reaction
with nephrin antibody recognizes the protein with the expected
size (B185 kDa) in the glomerular fraction. b-Actin antibody, used
as a loading control, recognizes a protein B40 kDa in both lanes.
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Hip1 colocalized with vimentin on the basal aspect of
immature podocytes. In maturing-stage glomerulus, staining
for Hip1 colocalized with vimentin both on the basal
aspects and at the apical membrane of developing podocytes
(Figure 5c). Taken together, Hip1 colocalized with major
process protein vimentin through glomerulogenesis, which
supports the idea that Hip1 associates with these cellular
projections.
Expression of Nfasc in mature and developing kidney
In RT–PCR, Nfasc was detected in the glomerulus, whereas
no fragment was observed in the rest of the kidney lacking
glomeruli (Figure 1). In western blot analysis, a band of
the expected size (B185 kDa, see ref. 8) in the glomerular
fraction was detected (Figure 1). Consistent with RT–PCR
results, no band was visible in the sample obtained from the
rest of the kidney.
Immunofluorescence was performed using two different
Nfasc antibodies, and both showed similar results (data not
shown). In adult human kidney, strong staining for Nfasc was
seen in the glomerulus, whereas no immunoreactivity was
observed outside of glomeruli (Figures 2b and 3e). In the
glomerulus, Nfasc was detected at the urinary side of nephrin
staining, and no overlapping reactivity was observed for these
proteins (Figure 3f and g). Instead, Nfasc appeared to localize
to the major processes, as it showed overlapping reactivity
with vimentin (Figure 3h). In immunoelectron microscopy
experiments, no reliable signal was observed for Nfasc.
During glomerulogenesis, vesicle and S-shaped-stage
glomeruli (the earliest developmental stages of the glome-
rulus) showed no Nfasc immunoreactivity (data not shown).
The signal for Nfasc was first observed at the capillary-stage
glomerulus, where the staining colocalized with the major
process marker vimentin (Figure 5d and e). In maturing
glomeruli, Nfasc expression was detected both on the basal
aspects and at the apical membrane of developing podocytes,
again, colocalizing with vimentin (Figure 5f). The similar
distribution of Nfasc with vimentin throughout podocyte
maturation supports the idea that Nfasc associates with
major processes.
Expression of Olfml2a in mature and developing kidney
RT–PCR analysis showed the expression of Olfml2a only in
the glomerular fraction in comparison with the rest of the
kidney lacking glomeruli (Figure 1). In the western blot
analysis, a band ofB110 kDa was detected in the glomerular
fraction. No band was observed in the rest of the kidney
fraction (Figure 1).
Immunofluorescence on adult kidney samples showed
intense staining in the glomerulus, whereas no immuno-
reactivity was seen outside of the glomeruli (Figures 2c
and 3i). Double labeling with nephrin did not demonstrate
colocalization (Figure 3j and k), as the Olfml2a signal was
found on the side of the urinary space from nephrin.
Double staining with vimentin revealed overlapping reacti-
vity (Figure 3l), indicating the presence of Olfml2a in major
Hip1
Nfasc
Olfml2a
Figure 2 | Expression of novel podocyte proteins, Huntingtin
interacting protein 1 (Hip1), neurofascin (Nfasc), and
olfactomedin-like 2a (Olfml2a), in the kidney as seen with
immunofluorescence staining. (a–c) All antibodies show intense
signal in the glomerular tufts of mature human kidney, whereas
no significant signal is detected outside of the glomeruli.
(a–c) Original magnification  80.
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processes. To confirm the subcellular location, immuno-
electron microscopy experiments were performed. This
demonstrated that the label for Olfml2a was mostly observed
in major processes. The labeling frequency was generally
rather weak, but from a total of 27 gold labels observed
in glomeruli 23 (85%) were found in major processes
(Figure 4b). Thus, Olfml2a was exclusively expressed by
podocytes in the kidney, wherein it localized to major
processes.
During glomerulogenesis, the vesicle-stage glomerulus
did not show any immunoreactivity for Olfml2a (data
not shown). Surprisingly, at the S-shaped stage, Olfml2a
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Figure 3 | Expression of novel podocyte proteins in the glomerulus as shown with double immunofluorescence labeling. Double
immunolabeling was performed with foot process marker nephrin (red) and major process marker vimentin (red). DAPI (4,6-diamidino-2-
phenylindole; a nuclear marker) staining is shown in blue. (a) Staining for Huntingtin interacting protein 1 (Hip1) in the kidney shows
a positive reactivity exclusively in the glomerulus. (b, c) Double labeling with nephrin shows only rare (arrow) overlapping. Hip1 is observed
at the urinary side of nephrin. (d) Double labeling with vimentin shows overlapping immunoreactivity (yellow) in major processes.
(e) Staining for neurofascin (Nfasc) gives an intense positive signal exclusively in the glomerulus. (f, g) Double labeling with nephrin does
not show any overlapping immunoreactivity, because Nfasc staining is found at the urinary side of nephrin. (h) Double labeling with
vimentin shows overlapping reactivity (yellow) in major processes. (i) Staining for olfactomedin-like 2a (Olfml2a) in the kidney shows specific
reactivity in the glomerulus. (j, k) Double labeling with nephrin does not show any overlapping immunoreactivity. Staining for Olfml2a
is located at the urinary side of nephrin. (l) Double labeling with vimentin shows overlapping reactivity (yellow) in major processes.
CS, capillary space; US, urinary space. Original magnifications: (a, b, e, f, i, j)  400; (c, d, g, h, k, l)  2000.
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presented positive signal in the invading endothelial cells
located in the glomerular cleft (data not shown). In later
stages, more mature endothelial cells did not express Olfml2a
(Figure 5g–i). Instead, at the capillary stage, a clear signal for
Olfml2a was observed at the basal aspects of developing
podocytes (Figure 5g and h), wherein Olfml2a colocalized
with vimentin. Similarly, at the maturing-stage glomerulus,
Olfml2a colocalized with vimentin on the basal aspects and
at the apical surface of developing podocytes (Figure 5h).
Thus, Olfml2a colocalized with the major process protein
vimentin throughout podocyte development, which strongly
supports the idea that this protein associates with major
processes.
Expression of novel podocyte markers in glomerular
crescents
The presence or absence of podocytes in glomerular crescents
has been a controversial issue.9,10 We used our novel podo-
cyte markers to clarify this interesting question. Immuno-
reactivity for Hip1 was observed in 14 of the 26 crescents
identified in our biopsy material (Figure 6a and b). In line
with this, Olfml2a staining was clearly detected in 21 of
the 31 glomerular crescents identified (Figure 6c and d). All
glomerular crescents positive for Hip1 and Olfml2a expres-
sion were cellular crescents, and less than half of the cells in
these lesions showed positive immunoreactivity (Figure 6a–d,
data not shown). Anti-Nfasc antibodies did not give a reliable
signal in the paraffin-embedded material (data not shown).
To validate our results, we analyzed the expression
of synaptopodin and Pdlim2 in glomerular crescents.
These proteins are molecular components of podocyte foot
processes, and, importantly, in the kidney, they are expressed
only by podocytes.2,11 Along with an established podocyte
marker synaptopodin, we chose Pdlim2 as a marker, because
during podocyte development it is expressed earlier than
other foot process markers, such as nephrin and synapto-
podin (data not shown). Here, immunostaining with anti-
synaptopodin antibody demonstrated a positive signal in
25 out of 40 glomerular crescents identified (Figure 6e and f).
Similarly, anti-Pdlim2 antibody demonstrated a positive
staining in 30 of the 43 glomerular crescents identified
(Figure 6g and h). All these crescents were classified as
cellular crescents. Taken together, cells in glomerular
crescents showed positivity for four podocyte markers.
Finally, to exclude that the cells showing positivity for
podocyte markers would originate from parietal epithelial
cells, we stained consecutive sections for cytokeratin 8 (CK8),
a marker for activated parietal epithelial cells.8 Staining for CK8
was detected in glomerular crescents, but these cells remained
negative for synaptopodin (Supplementary Figure S1 online).
In contrast, synaptopodin-positive cells in glomerular cres-
cents did not show CK8 staining.
DISCUSSION
Mutations in podocyte-enriched genes are the cause of
inherited forms of proteinuria.1 These genes show restricted
expression profiles outside of the podocyte, which reflects the
unique structure and function of podocytes in the filtration
barrier. In this study, we have identified three novel highly
podocyte-associated proteins: Hip1, Nfasc, and Olfml2a. In
the kidney, these proteins are expressed exclusively in
podocytes, wherein they localize to major processes. This is
intriguing, as the molecular composition of these peculiar
cytoplasmic extensions is poorly known. The restricted
expression in major processes suggests that these proteins
have a specialized functional role in these cellular processes.
Two of the proteins, Hip1 and Nfasc, have been previously
identified in neurons. Thus, these proteins can be added to a
long list of proteins shared by podocytes and neuronal cells.
Recently, Brunskill et al.12 characterized podocyte transcrip-
tome through microarray profiling and could similarly
confirm the neuronal-like molecular signature of podocytes.
This is not surprising as podocytes and neurons share many
structural features.
Hip1 has previously been studied mostly in the brain. It
was first described via its interaction with the Huntington’s
disease–causing protein, Huntingtin.13 Hip1 is known to be
an endocytic adaptor protein and has a role in clathrin-
mediated vesicle trafficking.14,15 It is present in a complex
with glutamate receptors, and studies in knockout animals
have shown that Hip1 facilitates glutamate signaling in
neurons.16 In this study, we identified Hip1 expression in
podocyte major processes. As glutamate signaling has been
reported to have a crucial role in podocytes,17 it is possible
that Hip1 promotes glutamate signaling in podocytes. In this
respect, the localization of Hip1 to major processes is
somewhat surprising, because in podocytes the slit dia-
phragm is thought to be involved in glutamate signaling.
During podocyte development, we observed Hip1 expression
as early as the capillary-stage glomerulus. This is in contrast
to the expression of other glutamate signaling proteins,
which are not expressed in immature podocytes.17 This,
together with the subcellular localization, suggests that Hip1
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Figure 4 | The subcellular distribution of novel podocyte
proteins in the glomerulus by immunoelectron microscopy.
(a) Immunogold particles (arrowheads) for Huntingtin interacting
protein 1 (Hip1) are found mostly in the major processes of
podocytes. Occasionally, label is found in foot processes.
(b) Immunogold particles (arrowheads) for olfactomedin-like 2a
(Olfm12a) were almost exclusively found in major processes.
Bars¼ 500 nm. FP, foot processes; GBM, glomerular basement
membrane; MP, major processes.
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may have another role than promoting glutamate signaling in
podocytes.
Nfasc is a member of the L1 cell adhesion transmembrane
molecules.18 The characteristic of L1 cell adhesion trans-
membrane molecules is an extracellular domain composed
of repetitive immunoglobulin-like and fibronectin-like
domains. The cytoplasmic domain binds ankyrin and a
member of ezrin–radixin–moesin proteins, and through
these, L1 cell adhesion transmembrane molecules are linked
to the actin cytoskeleton.18 In addition, the cytoplasmic tail
of Nfasc binds doublecortin, a microtubule-binding/stabiliz-
ing protein.19 This interaction may have an important role in
microtubular dynamics, because a mutation in the droso-
phila ortholog of Nfasc impairs the assembly of microtubules
in neurons.20 In line with this, Nfasc knockout mice die soon
after birth and display severe defects in the formation of
axons.21 Importantly, Nfasc has previously been thought to
be specific for the neuronal tissue, where three major
isoforms, NF155, NF166, and NF186 (named after the sizes
detected in sodium dodecyl sulfate–page gel), have been
identified.21 In this report, we have identified Nfasc as a novel
component of major processes in podocytes. In western
blotting, the size of glomerular Nfasc is B185 kD, which
probably represents the NF186 isoform. The restricted
expression of Nfasc in podocyte major processes is likely
linked to the presence of an extensive microtubular system in
these cellular processes. It is possible that Nfasc has a role in
the microtubular dynamics of major processes, similar to that
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Figure 5 | Expression of novel podocyte proteins in human glomerulogenesis as shown with immunofluorescence staining. The
sections were stained for Huntingtin interacting protein 1 (Hip1), neurofascin (Nfasc), and olfactomedin-like 2a (Olfml2a; green) for major
process marker vimentin (red) and nuclear marker 4,6-diamidino-2-phenylindole (DAPI; blue). (a, b) Hip1 expression is first detected during
the capillary stage. At this stage, Hip1 is localized at the basal aspects of developing podocytes, wherein it colocalizes (yellow) with
vimentin. (c) In maturing-stage glomeruli, Hip1 colocalizes with vimentin at the basal aspects and the apical membrane of developing
podocytes. (d, e) Nfasc expression is first detected at the capillary stage, wherein Nfasc is seen at the basal aspects of immature podocytes.
Vimentin colocalizes with Nfasc at this stage. (f) In maturing-stage glomeruli, staining for Nfasc overlaps with that of vimentin at the basal
aspects and the apical membrane of developing podocytes. (g, h) During podocyte development, Olfml2a is first detected at the capillary
stage, wherein Olfml2a is observed at the basal aspects of immature podocyte. The staining for Olfml2a overlaps with that of vimentin.
(i) In maturing glomeruli, Olfml2a expression is detected at the basal aspects and the apical surface of podocytes, and it colocalizes with
vimentin. (a–i) Original magnification  500. bs, Bowman’s space.
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seen in drosophila.20 In fact, we have identified Nfasc-bind-
ing protein doublecortin in major processes (L Sistani et al.,
unpublished data), which could link Nfasc to microtubules.
At present, we are generating a podocyte-specific knockout
mouse line for Nfasc to elucidate the functional role of this
protein in the kidney.
Olfml2a is a member of olfactomedin domain–containing
proteins. On the basis of its amino-acid sequence, Olfml2a is
predicted to be a secreted protein associating with the plasma
membrane. The function and expression pattern of Olfml2a
is unknown. It is noteworthy that the olfactomedin domain
of gliomedin, a protein that is found exclusively in the
nodes of Ranvier, binds to neurofascin, and this interaction
stabilizes these structures.22 As Olfml2a contains one
olfactomedin domain, it is possible that a similar interaction
exists in podocytes. More so, this view draws a link to the fact
that both Olfml2a and neurofascin are found only in major
processes. Thus, Olfm2a, neurofascin, and doublecortin may
serve as an important protein complex in major processes,
stabilizing microtubular structures. Unfortunately, similar to
neurofascin, Olfml2a is not expressed by immortalized
podocyte cells, which makes it difficult to study the function
of these proteins in cell culture.
Crescentic lesions are often observed in inflammatory
diseases affecting the glomerulus, and generally they are
considered as a histologic sign of severe injury.10 The glome-
rular crescents are recognized as a heterogeneous composi-
tion of cells and matrix, including leukocytes, renal cells, and
fibrin—all found between the capillary tuft and Bowman’s
capsule. However, the cellular composition of crescents is a
controversial subject, mainly because the presence and the
role of podocytes in the formation of these lesions has
remained unclear.10 In the past, podocytes have not been
regarded to take part in the formation of the glomerular
crescent. This idea has been supported by studies that do not
show any expression of podocyte markers in glomerular
crescents.9,23,24 However, data reporting the presence of
podocytes in these structures have emerged.25,26 In particular,
the data gained from a mouse model in which podocytes
have been genetically tagged suggest that podocytes are
present in glomerular crescents.26 In this study, our data
highlight the presence of podocytes in the glomerular
crescents of human patients. In the renal biopsies examined,
Hip1 and Olfml2a (identified as major processes markers),
as well as pdlim2 and synaptopodin (foot processes markers),
were clearly detected in the cellular components of
glomerular crescents. The presence of these markers in these
lesions suggests the participation of podocytes in the
pathological cascade of the glomerular crescent formation.
It is noteworthy that we also detected another subpopulation
of cells in crescents that were positive for CK8, a marker for
activated parietal epithelial cells, supporting the idea that
these cells also contribute to the formation of crescents.
The conflicting data reported on the presence of podo-
cytes and the lack of expression of various podocyte markers
in the glomerular crescents is an interesting question. One
reason for the contradictory results is that podocytes
dedifferentiate or transdifferentiate and lose their podocyte-
specific markers in parallel with the progression of disease.
Consequently, the antigens are not detected by the traditional
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Figure 6 | Expression of podocyte markers Huntingtin
interacting protein 1 (Hip1), olfactomedin-like 2a (Olfml2a),
Pdlim2, and synaptopodin in glomerular crescents using
immunoperoxidase staining. (a, b) Staining for Hip1 is detected
in the cellular components of glomerular crescents (arrow). The
staining is observed diffusely in the cytoplasm. (c, d) Olfml2a
immunoreactivity is detected in cells between the capillary tuft
and Bowman’s capsule (arrow). These cells are part of the
crescent. (e, f) Some cells in glomerular crescents show positivity
for Pdllim2 (arrow). Staining is observed diffusely in the
cytoplasm. (g, h) Staining for synaptopodin is detected in
glomerular crescents (arrow). Original magnifications:
(a, c, e, g)  60; (b, d, f, h)  300.
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immunohistochemistry approach in human material. This
explains the fact that only some crescents were positive
for podocyte markers in our study. These positive crescents
were all fresh crescents, which are likely to contain podocyte
cells that have maintained their differentiated phenotype.
In contrast to this, the cells in more chronic lesions were
negative for podocyte markers, which probably reflects the
progressive dedifferentiation of podocytes.
In summary, we have identified three novel podocyte
proteins that are, in the kidney, highly specific to podocyte
major processes. Given their specificity, these proteins are
likely to have a dedicated role in the biology of major
processes. Furthermore, by using new podocyte markers,
we show that podocytes are present in glomerular crescents.
Our findings provide novel insights into the molecular
composition of major processes and show that podocytes
contribute to the formation of glomerular crescents.
MATERIALS AND METHODS
RT–PCR
The expression of transcripts was analyzed in the mouse glomerulus
and the kidney fraction excluding the glomerulus with RT–PCR.
Glomeruli were isolated using a standard perfusion method. Primer
sequences were as follows: Hip1, left 50-GCTTCATGGAGCAGT
TCACA-30, right 50-GTCCTTGTTCACGCCATTTT-30; Nfasc, left
50-GAGGCCACTTTTCACAGAGC-30, right 50-ATAGGCAAACCAG
GACAACG-30; Olfml2a, left 50-CTGCTGCCTGATGTGGTCTA-30,
right 50-GTGAGCATCAGTGCCAGTGT-30. Podocin and glyceralde-
hyde 3–phosphate dehydrogenase primers were used in control reactions.
Antibodies
Polyclonal antibodies were generated by immunizing rabbits with
human recombinant proteins (residues: Hip1 663–772, Olfml2a
74–164). The protein fragments were expressed and purified as
described.27 Nfasc antibodies were purchased from Sigma (St Louis,
MO) and Abcam (Cambridge, UK).
Western blotting
Lysates of glomeruli and the kidneys lacking glomeruli were
obtained from cadaver kidneys unsuitable for transplantation
because of vascular abnormalities (from the fourth Department of
Surgery of Helsinki, Finland). Glomeruli were isolated using a
standard sieving method. Western blotting experiments were
performed according to standard procedures. Anti-b-actin antibody
(Abcam) served as a loading control.
Immunofluorescence
Adult human kidney samples were collected from cadaver kidneys
(see above). Samples from a developing kidney were obtained from an
embryo aborted at week 20 of pregnancy owing to neural tube defects
and hydrocephalus. The use of human material was accepted by the
local ethics committee. Immunofluorescence stainings were performed
as described.28,29 Double-labeling experiments were performed using
vimentin (Zymed Laboratories, San Francisco, CA), synaptopodin
(Progen, Heidelberg, Germany), and nephrin 50A9 (ref. 3) antibodies.
Immunoelectron microscopy
Immunoelectron microscopy experiments were performed as
described.28
Immunoperoxidase staining
Immunoperoxidase staining was performed using standard proce-
dures on renal biopsies from patients with crescentic glomerulo-
nephritis. The underlying diagnosis in all cases was ANCA-
positive vasculitis. Additional antibodies used in immunoperoxidase
stainings were as follows: pdlim2 (described previously in ref. 11),
synaptopodin (Progen), and CK8 antibody (Sigma).
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Figure S1. Expression of cytokeratin 8 (CK8) and synaptopodin in
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